Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: voogd ac. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707
Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression.
Elkhuizen PH, Voogd AC, van den Broek LC, Tan IT, van Houwelingen HC, Leer JW, van de Vijver MJ. Elkhuizen PH, et al. Among authors: voogd ac. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):73-83. doi: 10.1016/s0360-3016(99)00158-3. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477009 Clinical Trial.
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST).
Voogd AC, Peterse JL, Crommelin MA, Rutgers EJ, Botke G, Elkhuizen PH, van Geel AN, Hoekstra CJ, van Pel R, van de Vijver MJ, Coebergh JW. Voogd AC, et al. Eur J Cancer. 1999 Dec;35(13):1828-37. doi: 10.1016/s0959-8049(99)00220-8. Eur J Cancer. 1999. PMID: 10673999
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H. van Dongen JA, et al. Among authors: voogd ac. J Natl Cancer Inst. 2000 Jul 19;92(14):1143-50. doi: 10.1093/jnci/92.14.1143. J Natl Cancer Inst. 2000. PMID: 10904087 Clinical Trial.
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.
Voogd AC, van Oost FJ, Rutgers EJ, Elkhuizen PH, van Geel AN, Scheijmans LJ, van der Sangen MJ, Botke G, Hoekstra CJ, Jobsen JJ, van de Velde CJ, von Meyenfeldt MF, Tabak JM, Peterse JL, van de Vijver MJ, Coebergh JW, van Tienhoven G; Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group). Voogd AC, et al. Eur J Cancer. 2005 Nov;41(17):2637-44. doi: 10.1016/j.ejca.2005.04.040. Epub 2005 Aug 22. Eur J Cancer. 2005. PMID: 16115758
291 results